spray-drying,granulate,formulation
Novozymes Biopolymer develops, produces, and sells hyaluronic acid (HA) and other high-value biopolymers to forward-thinking partners within the technical, medical device, and pharmaceutical industries.
Until recently, hyaluronic acid was pretty much a commodity product. Today, our patented technology has created production opportunities that would have been impossible just a few short years ago – as well as safer, purer end-user products. Drawing on our direct access to world-class R&D, we have pioneered important new processes. Our state-of-art hyaluronic acid, HyaCare®, is the first hyaluronic acid (HA) that is 100% free of animal-derived raw materials and organic solvents. Using sophisticated spray-drying technology we supply a very consistent, pure and micro-granulate like powder that dissolves extremely fast, enabling production economy will be optimised through a faster formulation time.
And by working closely with our customers, we can custom-tailor product specifications so they meet individual formulation needs. In short, if you just want a supplier who will keep your production on schedule, you have many choices. But if you want to deal with people who will guarantee on time delivery and build your business, you need a true partner. For more and more companies, that partner is Novozymes Biopolymer.
Learn about Novozymes Biopolymer